Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Public health implications of legalising the production and sale of cannabis for medicinal and recreational use
Wayne Hall, Daniel Stjepanović, Jonathan P. Caulkins, et al.
The Lancet (2019) Vol. 394, Iss. 10208, pp. 1580-1590
Closed Access | Times Cited: 291

Showing 1-25 of 291 citing articles:

Global patterns of opioid use and dependence: harms to populations, interventions, and future action
Louisa Degenhardt, Jason Grebely, Jack Stone, et al.
The Lancet (2019) Vol. 394, Iss. 10208, pp. 1560-1579
Open Access | Times Cited: 615
Cannabis use and cannabis use disorder
Jason P. Connor, Daniel Stjepanović, Bernard Le Foll, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 308
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update
Benedikt Fischer, Tessa Robinson, Chris Bullen, et al.
International Journal of Drug Policy (2021) Vol. 99, pp. 103381-103381
Open Access | Times Cited: 136
Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada
Janni Leung, Gary Chan, Daniel Stjepanović, et al.
Psychopharmacology (2022) Vol. 239, Iss. 5, pp. 1509-1519
Open Access | Times Cited: 87
The implementation and public health impacts of cannabis legalization in Canada: a systematic review
Wayne Hall, Daniel Stjepanović, Danielle Dawson, et al.
Addiction (2023) Vol. 118, Iss. 11, pp. 2062-2072
Open Access | Times Cited: 46
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study
William Yang Wang, Nora D. Volkow, Nathan A. Berger, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 8, pp. 2587-2598
Open Access | Times Cited: 24
The association between physical availability of cannabis retail outlets and frequent cannabis use and related health harms: a systematic review
Nathan Cantor, Max Silverman, Adrienne Gaudreault, et al.
The Lancet Regional Health - Americas (2024) Vol. 32, pp. 100708-100708
Open Access | Times Cited: 19
Brain Function Outcomes of Recent and Lifetime Cannabis Use
Joshua L. Gowin, Jarrod M. Ellingson, Hollis C. Karoly, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2457069-e2457069
Open Access | Times Cited: 6
Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality
Daniel T. Myran, Michael Pugliese, André J. McDonald, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2457852-e2457852
Open Access | Times Cited: 3
Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence
Valentina Lorenzetti, Eva Hoch, Wayne Hall
European Neuropsychopharmacology (2020) Vol. 36, pp. 169-180
Closed Access | Times Cited: 115
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
Keith Cheung, Hassendrini N. Peiris, Geoff Wallace, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6079-6079
Open Access | Times Cited: 91
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
Zeinab Breijyeh, Buthaina Jubeh, Sabino Aurelio Bufo, et al.
Toxins (2021) Vol. 13, Iss. 2, pp. 117-117
Open Access | Times Cited: 84
COVID-19 and the health of people who use drugs: What is and what could be?
Jason Grebely, Magdalena Cerdá, Tim Rhodes
International Journal of Drug Policy (2020) Vol. 83, pp. 102958-102958
Open Access | Times Cited: 83
Will Legalization and Commercialization of Cannabis Use Increase the Incidence and Prevalence of Psychosis?
Robin M. Murray, Wayne Hall
JAMA Psychiatry (2020) Vol. 77, Iss. 8, pp. 777-777
Closed Access | Times Cited: 74
Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA
Vivian Chiu, Janni Leung, Wayne Hall, et al.
Neuropharmacology (2021) Vol. 193, pp. 108610-108610
Closed Access | Times Cited: 68
Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain
Filip Gedin, Sebastian Blomé, Moa Pontén, et al.
JAMA Network Open (2022) Vol. 5, Iss. 11, pp. e2243848-e2243848
Open Access | Times Cited: 67
Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark
Carsten Hjorthøj, Christine Merrild Posselt, Merete Nordentoft
JAMA Psychiatry (2021) Vol. 78, Iss. 9, pp. 1013-1013
Open Access | Times Cited: 64
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis
Deepak Cyril D’Souza, Marta Di Forti, Suhas Ganesh, et al.
The World Journal of Biological Psychiatry (2022) Vol. 23, Iss. 10, pp. 719-742
Closed Access | Times Cited: 63
Cannabis‐related allergies: An international overview and consensus recommendations
Isabel Skypala, Samira Jeimy, Hannelore Brucker, et al.
Allergy (2022) Vol. 77, Iss. 7, pp. 2038-2052
Open Access | Times Cited: 51
A Systematic Review of Trends in US Attitudes toward Cannabis Legalization
Vivian Chiu, Wayne Hall, Gary Chan, et al.
Substance Use & Misuse (2022) Vol. 57, Iss. 7, pp. 1052-1061
Closed Access | Times Cited: 44
Is legalization of recreational cannabis associated with levels of use and cannabis use disorder among youth in the United States? A rapid systematic review
Megan A. O’Grady, Marissa G. Iverson, Adekemi O. Suleiman, et al.
European Child & Adolescent Psychiatry (2022) Vol. 33, Iss. 3, pp. 701-723
Closed Access | Times Cited: 43
Cannabis Vaping Among Youth and Young Adults: a Scoping Review
Melissa B. Harrell, Stephanie L. Clendennen, Aslesha Sumbe, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 3, pp. 217-234
Open Access | Times Cited: 43
Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada
Daniel T. Myran, Rhiannon Roberts, Michael Pugliese, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2231937-e2231937
Open Access | Times Cited: 43
Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis
Tessa Robinson, Muhammad Usman Ali, Bethany Easterbrook, et al.
Psychological Medicine (2022) Vol. 53, Iss. 9, pp. 3858-3868
Open Access | Times Cited: 40
Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder
Oskar Hougaard Jefsen, Annette Erlangsen, Merete Nordentoft, et al.
JAMA Psychiatry (2023) Vol. 80, Iss. 8, pp. 803-803
Closed Access | Times Cited: 38
Page 1 - Next Page

Scroll to top